Clayton Financial Group LLC Bristol Myers Squibb CO Transaction History
Clayton Financial Group LLC
- $137 Billion
- Q3 2025
A detailed history of Clayton Financial Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clayton Financial Group LLC holds 4,896 shares of BMY stock, worth $212,437. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,896Holding current value
$212,437% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,672Shares Held
1.63BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...